Clinical Trial Update: Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating telithromycin for acute exacerbation of chronic bronchitis in adult outpatients with COPD; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Exacerbation of Chronic Bronchitis

Drugs mentioned

• Ketek (telithromycin)

Snippet

Sponsor: Sanofi | Conditions: Bronchitis, Chronic | Phase 4 | Status: COMPLETED